These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33226089)

  • 1. The association of opioid use duration and new depression episode among patients with and without insomnia.
    Salas J; Miller MB; Scherrer JF; Moore R; McCrae CS; Sullivan MD; Bucholz KK; Copeland LA; Ahmedani BK; Schneider FD; Lustman PJ
    J Opioid Manag; 2020 Sep/Oct 2020; 16(5):317-328. PubMed ID: 33226089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender and the Association between Long-Term Prescription Opioid Use and New-Onset Depression.
    Salas J; Scherrer JF; Ahmedani BK; Copeland LA; Bucholz KK; Sullivan MD; Burroughs T; Schneider FD; Lustman PJ
    J Pain; 2018 Jan; 19(1):88-98. PubMed ID: 29030323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of new depression diagnoses in patients with and without prior chronic opioid use.
    Scherrer JF; Salas J; Schneider FD; Bucholz KK; Sullivan MD; Copeland LA; Ahmedani BK; Burroughs T; Lustman PJ
    J Affect Disord; 2017 Mar; 210():125-129. PubMed ID: 28033519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription opioid analgesics increase the risk of depression.
    Scherrer JF; Svrakic DM; Freedland KE; Chrusciel T; Balasubramanian S; Bucholz KK; Lawler EV; Lustman PJ
    J Gen Intern Med; 2014 Mar; 29(3):491-9. PubMed ID: 24165926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription Opioid Duration, Dose, and Increased Risk of Depression in 3 Large Patient Populations.
    Scherrer JF; Salas J; Copeland LA; Stock EM; Ahmedani BK; Sullivan MD; Burroughs T; Schneider FD; Bucholz KK; Lustman PJ
    Ann Fam Med; 2016; 14(1):54-62. PubMed ID: 26755784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of prescription opioid use duration and dose on development of treatment resistant depression.
    Scherrer JF; Salas J; Sullivan MD; Schneider FD; Bucholz KK; Burroughs T; Copeland L; Ahmedani B; Lustman PJ
    Prev Med; 2016 Oct; 91():110-116. PubMed ID: 27497660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mental health conditions and the risk of chronic opioid therapy among patients with rheumatoid arthritis: a retrospective veterans affairs cohort study.
    Liberman JS; D'Agostino McGowan L; Greevy RA; Morrow JA; Griffin MR; Roumie CL; Grijalva CG
    Clin Rheumatol; 2020 Jun; 39(6):1793-1802. PubMed ID: 32036583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-onset depression following stable, slow, and rapid rate of prescription opioid dose escalation.
    Salas J; Scherrer JF; Schneider FD; Sullivan MD; Bucholz KK; Burroughs T; Copeland LA; Ahmedani BK; Lustman PJ
    Pain; 2017 Feb; 158(2):306-312. PubMed ID: 28092649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Risk of Depression Recurrence After Initiation of Prescription Opioids in Noncancer Pain Patients.
    Scherrer JF; Salas J; Copeland LA; Stock EM; Schneider FD; Sullivan M; Bucholz KK; Burroughs T; Lustman PJ
    J Pain; 2016 Apr; 17(4):473-82. PubMed ID: 26884282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of opioid prescriptions predicts incident nonmedical use of prescription opioids among U.S. veterans receiving medical care.
    Barry DT; Marshall BDL; Becker WC; Gordon AJ; Crystal S; Kerns RD; Gaither JR; Gordon KS; Justice AC; Fiellin DA; Edelman EJ
    Drug Alcohol Depend; 2018 Oct; 191():348-354. PubMed ID: 30176548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of posttraumatic stress disorder and prescription opioid use on risk of cardiovascular disease.
    Scherrer JF; Salas J; Lustman P; Tuerk P; Gebauer S; Norman SB; Schneider FD; Chard KM; van den Berk-Clark C; Cohen BE; Schnurr PP
    Eur J Prev Cardiol; 2020 Sep; 27(13):1412-1422. PubMed ID: 31084262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription opioid use duration and beliefs about pain and pain medication in primary care patients.
    Day P; Secrest S; Davis D; Salas J; van den Berk-Clark C; Kale N; Hearing C; Schneider FD; Scherrer JF;
    J Opioid Manag; 2020; 16(6):425-434. PubMed ID: 33428189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prescription Opioids and Depression Pathways Cohort Study.
    Scherrer JF; Ahmedani B; Autio K; Debar L; Lustman PJ; Miller-Matero LR; Salas J; Secrest S; Sullivan MD; Wilson L; Skiold-Hanlin S
    J Psychiatr Brain Sci; 2020; 5():. PubMed ID: 32542189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New depression diagnosis following prescription of codeine, hydrocodone or oxycodone.
    Scherrer JF; Salas J; Bucholz KK; Schneider FD; Burroughs T; Copeland LA; Sullivan MD; Lustman PJ
    Pharmacoepidemiol Drug Saf; 2016 May; 25(5):560-8. PubMed ID: 27004714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid Insomnia and Sleep Apnea are Associated with Greater Downstream Health Care Utilization and Chronic Opioid Use after Arthroscopic Hip Surgery.
    Rhon DI; Snodgrass SJ; Cleland JA; Cook CE
    Pain Physician; 2019 Jul; 22(4):E351-E360. PubMed ID: 31337179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of complementary and integrative health services and opioid therapy by patients receiving Veterans Health Administration pain care.
    Ashrafioun L; Allen KD; Pigeon WR
    Complement Ther Med; 2018 Aug; 39():8-13. PubMed ID: 30012396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study.
    Latif ZE; Šaltyte Benth J; Solli KK; Opheim A; Kunoe N; Krajci P; Sharma-Haase K; Tanum L
    JAMA Psychiatry; 2019 Feb; 76(2):127-134. PubMed ID: 30566177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between insomnia and prescription opioid use: results from a community sample in Northeast Florida.
    Serdarevic M; Osborne V; Striley CW; Cottler LB
    Sleep Health; 2017 Oct; 3(5):368-372. PubMed ID: 28923194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, pharmacotherapy and clinical correlates of diagnosed insomnia among Veterans Health Administration service users nationally.
    Hermes E; Rosenheck R
    Sleep Med; 2014 May; 15(5):508-14. PubMed ID: 24767725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insomnia severity and depressive symptoms in people living with HIV and chronic pain: associations with opioid use.
    Cody SL; Hobson JM; Gilstrap SR; Gloston GF; Riggs KR; Justin Thomas S; Goodin BR
    AIDS Care; 2022 Jun; 34(6):679-688. PubMed ID: 33625927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.